相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma
Rosa Nadal et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
Melanie Mahe et al.
EMBO MOLECULAR MEDICINE (2018)
The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data
Xian-Tao Zeng et al.
MEDICINE (2018)
Emerging biomarkers and targeted therapies in urothelial carcinoma
Prateek Mendiratta et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Epidemiology of urothelial carcinoma
Jun Miyazaki et al.
INTERNATIONAL JOURNAL OF UROLOGY (2017)
DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
Kelsy C Cotto et al.
NUCLEIC ACIDS RESEARCH (2017)
WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
Jing Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer
Sheng Li et al.
FRONTIERS IN PHYSIOLOGY (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence
Xiang-Yu Meng et al.
DISEASE MARKERS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
Mark D. M. Leiserson et al.
NATURE GENETICS (2015)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
Markus Riester et al.
CLINICAL CANCER RESEARCH (2014)
Microarray-based detection and expression analysis of extracellular matrix proteins in drug-resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
ONCOLOGY REPORTS (2014)
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Sandra Rebouissou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes
Anne Biton et al.
CELL REPORTS (2014)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer
Yann Neuzillet et al.
PLOS ONE (2012)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
Anne B. Als et al.
CLINICAL CANCER RESEARCH (2007)
Regional copy number-independent deregulation of transcription in cancer
Nicolas Stransky et al.
NATURE GENETICS (2006)
Sample size formula for proportional hazards modelling of competing risks
A Latouche et al.
STATISTICS IN MEDICINE (2004)
分享论文
